Inventor · disambiguated record
Danqing Wu
Also filed as: WU DANQING
7 granted patents·4 pending applications·24 citations·filing 2016–2024
84Inventor score
Files withNOVARTIS AG7SHANGHAI EPIMAB BIOTHERAPEUTICS CO LTD2ABEND JOHANNA1EPIMAB BIOTHERAPEUTICS HK LTD1
Top patents by PatentIndex Score
11 records- 0193US10654914B2Polyomavirus neutralizing antibodiesNOVARTIS AG·Filed 2018·Granted May 19, 2020·5 cites·21 claims
- 0291US11639378B2Polyomavirus neutralizing antibodiesNOVARTIS AG·Filed 2021·Granted May 2, 2023·1 cites·19 claims
- 0389US10435460B2Polyomavirus neutralizing antibodiesNOVARTIS AG·Filed 2017·Granted Oct 8, 2019·5 cites·26 claims
- 0489US2025051423A1Polyomavirus neutralizing antibodiesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0588US11161894B2Polyomavirus neutralizing antibodiesNOVARTIS AG·Filed 2019·Granted Nov 2, 2021·2 cites·21 claims
- 0688US10450366B2Polyomavirus neutralizing antibodiesNOVARTIS AG·Filed 2016·Granted Oct 22, 2019·5 cites·21 claims
- 0786US12077571B2Polyomavirus neutralizing antibodiesNOVARTIS AG·Filed 2023·Granted Sep 3, 2024·0 cites·20 claims
- 0884US9862760B2Polyomavirus neutralizing antibodiesABEND JOHANNA·Filed 2016·Granted Jan 9, 2018·6 cites·26 claims
- 0953US2025002594A1Anti-cd122 antibodies, anti-cd132 antibodies, and related bispecific binding proteinsSHANGHAI EPIMAB BIOTHERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 1051US2024010753A1Anti-ror1 antibodies and related bispecific binding proteinsEPIMAB BIOTHERAPEUTICS HK LTD·Filed 2021·Application pending·0 cites
- 1144US2023002489A1Antibodies to cd3 and bcma, and bispecific binding proteins made therefromSHANGHAI EPIMAB BIOTHERAPEUTICS CO LTD·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →